220 related articles for article (PubMed ID: 25466348)
41. [Patient treated with pirfenidone].
Valenzuela C
Arch Bronconeumol; 2012 Oct; 48 Suppl 2():19-20. PubMed ID: 23630973
[No Abstract] [Full Text] [Related]
42. Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis.
Glassberg MK; Wijsenbeek MS; Gilberg F; Petzinger U; Kirchgaessler KU; Albera C
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31164431
[TBL] [Abstract][Full Text] [Related]
43. [Novel therapies for idiopathic pulmonary fibrosis].
Wand O; Kremer MR
Harefuah; 2015 Jul; 154(7):446-50, 469, 468. PubMed ID: 26380465
[TBL] [Abstract][Full Text] [Related]
44. Idiopathic pulmonary fibrosis: an update.
Spagnolo P; Sverzellati N; Rossi G; Cavazza A; Tzouvelekis A; Crestani B; Vancheri C
Ann Med; 2015 Feb; 47(1):15-27. PubMed ID: 25613170
[TBL] [Abstract][Full Text] [Related]
45. Landmark approvals in idiopathic pulmonary fibrosis.
Ratner M
Nat Biotechnol; 2014 Nov; 32(11):1069-70. PubMed ID: 25380420
[No Abstract] [Full Text] [Related]
46. Real world experiences: pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis.
Chaudhuri N; Duck A; Frank R; Holme J; Leonard C
Respir Med; 2014 Jan; 108(1):224-6. PubMed ID: 24269005
[TBL] [Abstract][Full Text] [Related]
47. 2014 American Thoracic Society International Conference.
Kang S
Lancet Respir Med; 2014 Jul; 2(7):518-20. PubMed ID: 25140364
[No Abstract] [Full Text] [Related]
48. [Idiopathic pulmonary fibrosis].
Cottin V
Rev Prat; 2014 Sep; 64(7):923-8, 930-2. PubMed ID: 25362769
[TBL] [Abstract][Full Text] [Related]
49. Recommendations for perioperative management of new pharmacological antifibrotic therapy in idiopathic pulmonary fibrosis.
González Larrocha O; Romero Rojano P; Ortega Mera U; Arízaga Maguregui A
Rev Esp Anestesiol Reanim (Engl Ed); 2018 Mar; 65(3):178-179. PubMed ID: 29183632
[No Abstract] [Full Text] [Related]
50. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.
King TE; Albera C; Bradford WZ; Costabel U; du Bois RM; Leff JA; Nathan SD; Sahn SA; Valeyre D; Noble PW
Am J Respir Crit Care Med; 2014 Apr; 189(7):825-31. PubMed ID: 24476390
[TBL] [Abstract][Full Text] [Related]
51. [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].
Funke-Chambour M; Geiser T
Ther Umsch; 2016; 73(1):25-9. PubMed ID: 26884217
[TBL] [Abstract][Full Text] [Related]
52. Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice.
Okuda R; Hagiwara E; Baba T; Kitamura H; Kato T; Ogura T
Respir Med; 2013 Sep; 107(9):1431-7. PubMed ID: 23849626
[TBL] [Abstract][Full Text] [Related]
53. Idiopathic pulmonary fibrosis.
Dempsey OJ; Miller D
BMJ; 2013 Nov; 347():f6579. PubMed ID: 24201334
[No Abstract] [Full Text] [Related]
54. The evolving pharmacotherapy of pulmonary fibrosis.
Lota HK; Wells AU
Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
[TBL] [Abstract][Full Text] [Related]
55. Idiopathic pulmonary fibrosis: the role of the pharmacy benefit manager in providing access to effective, high-value care.
Morrow TJ
Am J Manag Care; 2015 Oct; 21(14 Suppl):s294-301. PubMed ID: 26788616
[TBL] [Abstract][Full Text] [Related]
56. Pirfenidone: a novel agent for the treatment of idiopathic pulmonary fibrosis.
Potts J; Yogaratnam D
Ann Pharmacother; 2013 Mar; 47(3):361-7. PubMed ID: 23404802
[TBL] [Abstract][Full Text] [Related]
57. Pirfenidone should be prescribed for patients with idiopathic pulmonary fibrosis.
Jenkins G
Thorax; 2013 Jul; 68(7):603-5. PubMed ID: 23462153
[No Abstract] [Full Text] [Related]
58. The Influence of Sex on Prognosis of Patients With Idiopathic Pulmonary Fibrosis in a Retrospective Cohort.
Caro FM; Alberti ML; Fernández ME; Paulin F
Arch Bronconeumol; 2017 Nov; 53(11):649-650. PubMed ID: 28483342
[No Abstract] [Full Text] [Related]
59. Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.
Oltmanns U; Kahn N; Palmowski K; Träger A; Wenz H; Heussel CP; Schnabel PA; Puderbach M; Wiebel M; Ehlers-Tenenbaum S; Warth A; Herth FJ; Kreuter M
Respiration; 2014; 88(3):199-207. PubMed ID: 25115833
[TBL] [Abstract][Full Text] [Related]
60. Idiopathic pulmonary fibrosis: recent milestones in disease management.
Costabel U
Eur Respir Rev; 2012 Jun; 21(124):140. PubMed ID: 22654085
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
